The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Poly(ADP-ribose) signaling in cell death
Open accessAbstract
Poly(ADP-ribosyl)ation (PARylation) is a reversible protein modification carried out by the concerted actions of poly(ADP-ribose) polymerase (PARP) enzymes and poly(ADP-ribose) (PAR) decomposing enzymes such as PAR glycohydrolase (PARG) and ADP-ribosyl hydrolase 3 (ARH3). Reversible PARylation is a pleiotropic regulator of various cellular functions but uncontrolled PARP activation may also lead to cell death. The cellular demise pathway mediated by PARylation in oxidatively stressed cells has been described almost thirty years ago. However, the underlying molecular mechanisms have only begun to emerge relatively recently. PARylation has been implicated in necroptosis, autophagic cell death but its role in extrinsic and intrinsic apoptosis appears to be less predominant and depends largely on the cellular model used. Currently, three major pathways have been made responsible for PARP-mediated necroptotic cell death: (1) compromised cellular energetics mainly due to depletion of NAD, the substrate of PARPs; (2) PAR mediated translocation of apoptosis inducing factor (AIF) from mitochondria to nucleus (parthanatos) and (3) a mostly elusive crosstalk between PARylation and cell death/survival kinases and phosphatases. Here we review how these PARP-mediated necroptotic pathways are intertwined, how PARylation may contribute to extrinsic and intrinsic apoptosis and discuss recent developments on the role of PARylation in autophagy and autophagic cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“parthanatos appears to occur not only as a consequence of severe/prolonged alkylating DNA damage, but also in response to oxidative stress, hypoxia, hypoglycemia, or inflammatory cues [656–658].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [657]
Citations
Cites
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Cited by
Sorted by citations
Items 101–200 of 276
El‐Hamoly, T., Hegedűs, C., Lakatos, P., Kovács, K. É., Bai, P., El‐Ghazaly, M. A., El-Denshary, E.-E. S. M., Szabó, É., & Virág, L. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00130 · Cited by 35
“Compromised cellular energetics may lead to cell dysfunction or even to (necroptotic) cell death (14).”
BackgroundSelf-citationReductive stress: The key pathway in metabolic disorders induced by overnutrition
Zhang, S., Wang, N., Gao, Z., Gao, Z., Wang, X., Xie, H., Wang, C.-Y., & Zhang, S. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.012 · Cited by 40
“Both NAD + depletion and excessive NADH can activate apoptotic programs, such as those mediated by the NAD + -consuming enzyme PARP, which influences apoptosis [87].”
Wang, X., Wang, Y., Parapanov, R., Abdelnour, E., Gronchi, F., Perentes, J. Y., Piquilloud, L., Ris, H., Letovanec, I., Liaudet, L., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001183 · Cited by 33
“Poly(ADP-ribose) polymerase uses NAD as a donor of ADP-ribose units and attaches them to multiple cellular proteins, modulating their biological activities.(8) Such “PARylation” is critical for DNA repair, which is the basis for the development of PARP inhibitors as anticancer drugs.”
BackgroundInfluentialBorghetti, G., Yamaguchi, A. A., Aikawa, J., Yamazaki, R. K., de Brito, G. A. P., & Fernandes, L. C. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0098-y · Cited by 32
“During cell death, detection of the cleaved PARP - 1 is regarded to be a hallmark of apoptosis [19, 21].”
BackgroundDemény, M. Á., & Virág, L. (2021) · Cancers · doi:10.3390/cancers13092057 · Cited by 33
Self-citationTheStreptococcus pyogenes NAD+glycohydrolase modulates epithelial cell PARylation and HMGB1 release
Chandrasekaran, S., & Caparon, M. G. (2015) · Cellular Microbiology · doi:10.1111/cmi.12442 · Cited by 32
“…of membrane permeability and is temporally modulated by NADase activity Because PARP-1 has multiple roles in cell regulation, PAR production is tightly controlled and transient, with degradation typically occurring within several minutes of PARP activation (Zhang et al., 2007; Virag et al., 2013).”
BackgroundInfluentialMaus, F., Sakry, D., Binamé, F., Karram, K., Rajalingam, K., Watts, C., Heywood, R. M., Krüger, R., Stegmüller, J., Werner, H. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137311 · Cited by 32
“necrosis [35].”
Li, X., Ling, Y., Cao, Z., Shen, J., Chen, S., Liu, W., Yuan, B.-L., & Wen, S. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.01.007 · Cited by 31
Herriott, A., Tudhope, S. J., Junge, G., Rodrigues, N., Patterson, M. J., Woodhouse, L. C., Lunec, J., Hunter, J. E., Mulligan, E. A., Cole, M. F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6287 · Cited by 30
“PARP has been implicated in the apoptotic process; not only is it cleaved by caspases but PAR formation promotes apoptosis inducing factor release from the mitochondrion and nuclear translocation triggering caspase-independent apoptosis [16].”
Walzik, D., Jonas, W., Joisten, N., Belen, S., Wüst, R. C. I., Guillemin, G. J., & Zimmer, P. (2023) · Acta Physiologica · doi:10.1111/apha.13921 · Cited by 33
The molecular mosaic of regulated cell death in the cardiovascular system
Martens, M. D., Karch, J. M., & Gordon, J. W. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166297 · Cited by 31
Korkmaz‐Icöz, S., Szczęsny, B., Marcatti, M., Li, S., Ruppert, M., Lasitschka, F., Loganathan, S., Szabó, C., & Szabo, G. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13983 · Cited by 30
Targeting ADP-ribosylation as an antimicrobial strategy
Catara, G., Corteggio, A., Valente, C., Grimaldi, G., & Palazzo, L. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.001 · Cited by 29
“In the following decades, research in the field has expanded the involvement of ADPr in the pathophysiology of diverse cellular processes in all domains of life, which include DNA damage repair [9] [10] [11] 14, [74] [75] [76] [77] [78] , cell metabolism [78] [79] [80] , aging [81] , cell division [16] [17] [18] [19]…”
BackgroundAPE1 polymorphic variants cause persistent genomic stress and affect cancer cell proliferation
Lirussi, L., Antoniali, G., DˈAmbrosio, C., Scaloni, A., Nilsen, H. L., & Tell, G. (2016) · Oncotarget · doi:10.18632/oncotarget.8477 · Cited by 28
Novel Insights into YB-1 Signaling and Cell Death Decisions
Shah, A., Lindquist, J. A., Rosendahl, L., Schmitz, I., & Mertens, P. R. (2021) · Cancers · doi:10.3390/cancers13133306 · Cited by 27
Polycation-Mediated Integrated Cell Death Processes
Parhamifar, L., Andersen, H. B., Wu, L., Hall, A., Hudzech, D., & Moghimi, S. M. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00012-2 · Cited by 29
Shankar, E., Franco, D., Iqbal, O., Moreton, S. A., Kanwal, R., & Gupta, S. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115200 · Cited by 28
Kang, X.-F., Lu, X.-L., Bi, C.-F., Hu, X.-D., Li, Y., Li, J., Yang, L., Liu, J., Ma, L., & Zhang, J. (2023) · Aging · doi:10.18632/aging.204990 · Cited by 27
Hu, W., Zhou, P., Rao, T., Zhang, X., Wang, W., & Zhang, L. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.024 · Cited by 27
50Years of poly(ADP-ribosyl)ation
Virág, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.05.002 · Cited by 27
Self-citationThe Role of HECT-Type E3 Ligase in the Development of Cardiac Disease
Goto, J., Otaki, Y., Watanabe, T., & Watanabe, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116065 · Cited by 26
Tiwari, P., Khan, H., Singh, T. G., & Grewal, A. K. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03595-z · Cited by 28
“Few of those kinases include calcium/calmodulin-dependent protein kinase β (CaMKKβ), LKB1, and transforming-growth factor β- activated kinase (TAK1) [120].”
BackgroundPARP-1 mediated cell death is directly activated by ZIKV infection
Xu, G., Li, S., Liu, X., Gao, P., Chen, X., Wang, H., Zhang, M., Yang, Y., Gao, G. F., & Zhang, F. (2019) · Virology · doi:10.1016/j.virol.2019.08.024 · Cited by 27
Suppressing PARylation by 2′,5′‐oligoadenylate synthetase 1 inhibits DNA damage‐induced cell death
Kondratova, A. A., Cheon, H., Dong, B., Holvey-Bates, E. G., Hasipek, M., Taran, I., Gaughan, C., Jha, B. K., Silverman, R. H., & Stark, G. R. (2020) · The EMBO Journal · doi:10.15252/embj.2019101573 · Cited by 27
“This process is termed PAR-mediated necroptosis or parthanatos (Wang et al , 2009, 2016; Virag et al , 2013).”
Proteome-wide microarray-based screening of PAR-binding proteins
Kang, B. G., Kang, S.-U., Kim, J. J., Kwon, J.-S., Gagné, J., Lee, S. Y., Kim, S., Lee, K. S., Ha, S., Jeong, J. S., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf300 · Cited by 23
Identification of ADP-ribosylated peptides and ADP-ribose acceptor sites
Rosenthal, F. (2014) · Frontiers in bioscience · doi:10.2741/4266 · Cited by 30
“Nucleic Acids Res, 38(19), 6350-6362 (2010)”
BackgroundQiu, D., Zhou, M., Lin, T., Chen, J., Wang, G., Huang, Y., Jiang, X., Tian, W., & Chen, H. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00680 · Cited by 26
Wang, Y., Yin, S., Zhou, Y., Zhou, W., Chen, T., Wu, Q., Zhou, L., & Zheng, S. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.34876 · Cited by 25
“PAR is polymerized by PARP-1, a downstream target of activated caspase 3, within the nucleus [30, 31, 32].”
BackgroundXue, Q., Liu, X., Chen, C., Zhang, X., Xie, P., Liu, Y., Zhou, S.-N., & Tang, J. Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00571-4 · Cited by 26
Ye, S., Cheng, Z., Zhuo, D., & Liu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158126 · Cited by 27
“Uncontrolled activation of PARP can lead to various cell death mechanisms, including apoptosis, pyroptosis, and parthanatos, among others [20].”
BackgroundYing, W. (2013) · Scientifica · doi:10.1155/2013/691251 · Cited by 25
Involvement of PARPs in cell death
Aredia, F. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/707 · Cited by 24
“The common denominator of the involvement of poly(ADP-ribosylation) in different paradigms of cell death is represented by PAR (17), which can drive cells into diverse (and sometimes opposite) manners to die (18-22).”
BackgroundSrinivasan, L., Gurses, S. A., Hurley, B. E., Miller, J. L., Karakousis, P. C., & Briken, V. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005652 · Cited by 22
Liu, F., Jiang, N., Xiao, Z.-Y., Cheng, J., Mei, Y.-Z., Zheng, P., Wang, L., Zhang, X., Zhou, X., Zhou, W., et al. (2016) · PeerJ · doi:10.7717/peerj.1890 · Cited by 23
“It has been reported that PARP-1 deficiency can reduce autophagy 486 due, in part, to the lack of inhibition of mTOR (Virag et al., 2013).”
BackgroundXu, Q., Zhu, D. Y., Wang, G., Lin, T., Sun, C., Ding, R., Tian, W., & Chen, H. (2020) · Natural Product Research · doi:10.1080/14786419.2020.1739044 · Cited by 23
“Poly (ADP-ribose) polymerase (PARP) is a family of proteins involved in many cellular processes such as programmed cell death, DNA repair and genomic stability (Vir ag et al. 2013).”
BackgroundDNA Double Strand Break and Response Fluorescent Assays: Choices and Interpretation
Atkinson, J., Bezak, E., Le, H. V., & Kempson, I. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042227 · Cited by 25
“This includes the regulation of gene transcription [59], cell death [60–62], pro-inflammatory cytokines [63,64], and viral immunity [65].”
BackgroundPoly(ADP‐ribosyl)ation is involved in pro‐survival autophagy in porcine blastocysts
Lee, H. R., Gupta, M. K., Kim, D. H., Hwang, J. H., Kwon, B., & Lee, H. T. (2015) · Molecular Reproduction and Development · doi:10.1002/mrd.22588 · Cited by 23
“PARylation can influence cell fate by initiating a pro-survival autophagic response that protects cells from apoptosis (Virag et al., 2013), particularly in response to cellular stress (Rodriguez-Vargas et al., 2012).”
BackgroundInfluentialRobaszkiewicz, A., Valkó, Z., Kovács, K. É., Hegedűs, C., Bakondi, E., Bai, P., & Virág, L. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.027 · Cited by 23
Self-citationAredia, F., Czaplinski, S., Fulda, S., & Scovassi, A. I. (2016) · BMC Cancer · doi:10.1186/s12885-016-2878-9 · Cited by 23
“5c), suggesting a possible requirement of PAR in the autophagy machinery [25, 30].”
BackgroundBriggs, A. G., Adams-Phillips, L. C., Keppler, B. D., Zebell, S. G., Arend, K. C., Apfelbaum, A. A., Smith, J. A., & Bent, A. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190268 · Cited by 23
Zhang, X., Huo, X., Guo, H., & Xue, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.965244 · Cited by 23
“2019), resulting in divergent cell fates, such as survival or apoptosis (Virag et al., 2013).”
BackgroundChandrasekaran, S., & Caparon, M. G. (2016) · mBio · doi:10.1128/mbio.02215-15 · Cited by 22
“Since MAPK activation can trigger several pathways of programmed necrotic cell death (24, 25), infected HeLa cells were examined for phosphorylation of members of the three most prominent MAPK subfamilies, including p38, ERK, and JNK.”
BackgroundMartín‐Guerrero, S. M., Casado, P., Hijazi, M., Rajeeve, V., Plaza‐Díaz, J., Abadía‐Molina, F., Navascués, J., Cuadros, M. Á., Cutillas, P. R., & Martín‐Oliva, D. (2020) · Biochemical Journal · doi:10.1042/bcj20200525 · Cited by 21
Rotin, L. E., Gronda, M., MacLean, N., Hurren, R., Wang, X., Lin, F.-H., Wrana, J. L., Datti, A., Barber, D. L., Minden, M. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6409 · Cited by 22
Atorvastatin suppresses the progression of cervical cancer via regulation of autophagy.
Sheng, B., Song, Y., Zhang, J., Li, R., Wang, Z. P., & Zhu, X. (2020) · PubMed Central · Cited by 20
Regdon, Z., Demény, M. Á., Kovács, K. É., Hajnády, Z., Nagy‐Pénzes, M., Bakondi, E., Kiss, A., Hegedűs, C., & Virág, L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15344 · Cited by 20
Self-citationWang, C., Li, Z., Zhao, B., Wu, Y., Fu, Y., Kang, K., Li, Y., Dong, L., Li, X., Zhang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6677955 · Cited by 21
“To further confirm that I/R induced apoptosis, we measured the accumulation of cleaved PARP, an important apoptosis marker [26], using western blot analysis.”
MethodManco, G., Lacerra, G., Porzio, E., & Catara, G. (2022) · Biomolecules · doi:10.3390/biom12030443 · Cited by 23
Faltz, M., Bergin, H., Pilavachi, E., Grimwade, G., & Mabley, J. G. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9397-4 · Cited by 20
“18 PARP activation has been shown to mediate both necrosis and apoptosis (21).”
BackgroundInfluentialMitochondria as Regulators of Nonapoptotic Cell Death in Cancer
Malla, S., Neupane, R., Sood, S., Hussein, N. A., Abou-Dahech, M. S., Terrero, D., Ashby, C. R., Babu, R. J., & Tiwari, A. K. (2025) · MedComm · doi:10.1002/mco2.70244 · Cited by 20
“…a number of biological functions, including the maintenance of the genome and repair of DNA and acting as a DNA damage sensor [403–405] and regulating other metabolic and homeostatic processes, such as cell death [406–408], gene transcription [409, 410], protein turnover, and inflammation [411].”
Bürkel, F., Jost, T., Hecht, M., Heinzerling, L., Fietkau, R., & Distel, L. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239321 · Cited by 19
“DNA damage, if not repaired, is a powerful activator of cell death such as apoptosis and necrosis [17,85,86].”
BackgroundPoly(ADP-ribosylation) and neurodegenerative disorders
Basello, D. A., & Scovassi, A. I. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.07.005 · Cited by 19
“repair and transcription (Bürkle, 2005; Bürkle and Virág, 2013; Krietsch et al., 2013; Virág et al., 2013).”
BackgroundChhabra, R., Grabrucker, A. M., Veratti, P., Belletti, D., Boeckers, T. M., Vandelli, M. A., Forni, F., Tosi, G., & Ruozi, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.054 · Cited by 19
Kim‐Campbell, N., Gómez, H., & Bayır, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00020-0 · Cited by 18
Liu, F., WU, A.-H., Zhou, S.-J., Deng, Y.-L., Zhang, Z.-Y., Zhang, E.-L., & Huang, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3248 · Cited by 19
“We then tested the effects of minocycline treatment on other apoptotic factors induced by mitochondria (25,26), Minocycline did not affect the intrinsic mitochondrial apoptotic pathway.”
BackgroundThe Interplay between Dysregulated Metabolism and Epigenetics in Cancer
Bassal, M. A. (2023) · Biomolecules · doi:10.3390/biom13060944 · Cited by 19
Cell death classification: A new insight based on molecular mechanisms
Dehghan, S., Kheshtchin, N., Hassannezhad, S., & Soleimani, M. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113860 · Cited by 21
Lede, V., Meusel, A., Garten, A., Popkova, Y., Penke, M., Franke, C., Ricken, A. M., Schulz, A., Kieß, W., Huster, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172000 · Cited by 18
“Reasons for the detected decrease in NAD levels could be an enhanced degradation of NAD by poly(ADP-ribose) polymerase 1 (Parp-1) [40] or Cd38 [41].”
BackgroundPARP-1 may be involved in hydroquinone-induced apoptosis by poly ADP-ribosylation of ZO-2
Liu, J., Yuan, Q., Ling, X., Tan, Q., Liang, H., Chen, J., Lin, L., Xiao, Y., Chen, W. L., Liu, L., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7643 · Cited by 18
“Activated PARP-1 and PARylation regulate various cellular machineries, including those involved in cell death (6).”
Protein Kinase-Mediated Decision Between the Life and Death
Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_1 · Cited by 20
USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy
Wang, D., Jiang, Z., Kan, J., Jiang, X., Pan, C., You, S., Chang, R., Zhang, J., Yang, H., Zhu, L., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111070 · Cited by 17
Batnasan, E., Xie, S., Zhang, Q., & Li, Y. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00005-8 · Cited by 17
Muñoz, F. M., Zhang, F., Islas‐Robles, A., Lau, S. S., & Monks, T. J. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx106 · Cited by 17
Nagy‐Pénzes, M., Hajnády, Z., Regdon, Z., Demény, M. Á., Kovács, K. É., El‐Hamoly, T., Maléth, J., Hegyi, P. J., Hegedűs, C., & Virág, L. (2022) · Biomedicines · doi:10.3390/biomedicines10061371 · Cited by 16
“Of note, the oxidative stress-induced and PARP1-mediated cell death pathway displays features of necrosis (including membrane permeabilization) [66], which are in line with the primarily necrotic nature of acinar cells in AP.”
BackgroundSelf-citationZhu, Z., Cao, Y., Liu, L., Zhao, Z., Yin, H., & Wang, H. (2022) · Korean journal of urology · doi:10.4111/icu.20210411 · Cited by 16
“In addition to caspases, signal molecules such as PARP have been reported to participate in the apoptosis pathway, which is the main substrate of caspase-3 [21].”
BackgroundCho, C., Chien, C., Chiu, Y., Lin, M.-H., & Hsu, C. (2019) · Nature Communications · doi:10.1038/s41467-019-09153-6 · Cited by 16
Therapeutic Application of PARP Inhibitors in Neuro-Oncology
Ning, J., & Wakimoto, H. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.004 · Cited by 16
Endothelial SIRT6 deficiency promotes arterial thrombosis in mice
Gaul, D. S., Calatayud, N., Pahla, J., Bonetti, N. R., Wang, Y.-J., Weber, J., Ambrosini, S., Liberale, L., Costantino, S., Mohammed, S. A., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.11.005 · Cited by 15
Targeting Oxidative Stress in Stroke
Bach, A. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_8 · Cited by 15
Roles of Nicotinamide Adenine Dinucleotide (NAD+) in Biological Systems
Poltronieri, P., & Čereković, N. (2018) · Challenges · doi:10.3390/challe9010003 · Cited by 15
El‐Hamoly, T., Hajnády, Z., Nagy‐Pénzes, M., Bakondi, E., Regdon, Z., Demény, M. Á., Kovács, K. É., Hegedűs, C., El‐Rahman, S. S. A., Szabó, É., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073593 · Cited by 15
Self-citationZheng, J., Long, M., Qin, Z., Fen, W., Chen, Z., & Li, L. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.699 · Cited by 15
Luan, Y., Cao, X., Zhang, L., Peng, Y., Li, Y.-Y., & Yin, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108809 · Cited by 13
Schlesinger, M., Larrea, S. C. V., Haikarainen, T., Narwal, M., Venkannagari, H., Flawiá, M. M., Lehtiö, L., & Villamil, S. H. F. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1461-1 · Cited by 14
“lecular switch between different cell death pathways [8].”
BackgroundThe role of dePARylation in DNA damage repair and cancer suppression
Kassab, M. A., & Yu, X. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.02.002 · Cited by 14
Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury
Haga, S., Kanno, A., Morita, N., Jin, S., Matoba, K., Ozawa, T., & Ozaki, M. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.09.008 · Cited by 13
Poly(ADP-ribose) in the bone: From oxidative stress signal to structural element
Hegedűs, C., Robaszkiewicz, A., Lakatos, P., Szabó, É., & Virág, L. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.027 · Cited by 13
Self-citationNucleotide sugar profiles throughout development in wildtype and galt knockout zebrafish
Haskovic, M., Coelho, A. I., Lindhout, M., Zijlstra, F., Veizaj, R., Vos, R., Vanoevelen, J. M., Bierau, J., Lefeber, D. J., & Rubio‐Gozalbo, M. E. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12265 · Cited by 13
Lee, H. R., Kim, D. H., Kim, M. G., Lee, J. S., Hwang, J. H., & Lee, H. T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.148 · Cited by 13
Sena, P., Manfredini, G., Benincasa, M., Mariani, F., Smargiassi, A., Catani, F., & Palumbo, C. (2014) · Journal of Anatomy · doi:10.1111/joa.12176 · Cited by 12
“Activation of PARP may cause regulated necrosis via three major pathways that are likely to be closely intertwined (Vir (cid:1) ag et al. 2013): (i) compromised cellular energetic balance mainly due to depletion of NAD, the substrate of PARPs; (ii) PAR-mediated translocation of apoptosis inducing…”
Filliol, A. A., Piquet‐Pellorce, C., Dion, S., Genêt, V., Lucas‐Clerc, C., Dantzer, F., & Samson, M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00436.2016 · Cited by 12
“In the last decades, PARP1 and PARP2 have also been found to play an important role in inflammation (4) and cell death (30).”
BackgroundZhu, Z., Weng, S., Zheng, F., Zhao, Q., Xu, Y., & Wu, J. (2023) · Phenomics · doi:10.1007/s43657-023-00112-2 · Cited by 11
“For example, excessive PARylation results in significant depletion of intracellular NAD + and adenosine triphosphate (ATP) levels, leading to cellular viability loss accompanied by necrotic cell death characteristics (Virág et al. 2013).”
Indirubin 3′-Epoxide Induces Caspase-Independent Cell Death in Human Neuroblastoma
Kurita, M., Hanada, S., Ichimaru, Y., Saito, H., Tabata, K., Asami, S., Miyairi, S., & Suzuki, T. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00999 · Cited by 11
Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone via TP53INP1 Signaling
Xiao, W., Zong, Z., Qiu, M., Chen, X., Shen, H., & Lao, L. (2018) · Orthopaedic Surgery · doi:10.1111/os.12414 · Cited by 11
Zhang, Z.-H., Zhang, Z., Chen, M.-W., Yang, Y. N., Li, R.-J., Xu, J.-J., Yang, C. B., Li, Y.-Y., Chen, H.-W., Liu, S., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1115749 · Cited by 11
“However, persistent excessive activation of PARylation promotes depletion of NAD + and ATP, leading to further cell death [31].”
Kim, S., To, D. C., Nguyễn, P. H., Nguyễn, Y. N., Cho, B.-J., & Tran, M. H. (2020) · Molecules · doi:10.3390/molecules25204800 · Cited by 11
Walter, A. E., Herrold, A. A., Gallagher, V. T., Lee, R., Scaramuzzo, M., Bream, T., Seidenberg, P. H., Vandenbergh, D. J., O’Connor, K. P., Talavage, T. M., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5622 · Cited by 10
“50,51 It is also involved in TBI neuroprotective effects through reducing the neu-roimmune response.”
p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates
Dutto, I., Sukhanova, M. V., Tillhon, M., Cazzalini, O., Stivala, L. A., Scovassi, A. I., Lavrik, O. I., & Prosperi, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146031 · Cited by 10
Coordination of DNA Base Excision Repair by Protein-Protein Interactions
Moor, N. A., & Lavrik, O. I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82642 · Cited by 10
Васин, М. В., & Ушаков, И. Б. (2019) · Biology Bulletin Reviews · doi:10.1134/s2079086419060082 · Cited by 10
Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Amuzu, S., Carmona, E., Mes‐Masson, A., Greenwood, C. M. T., Tonin, P. N., & Ragoussis, J. (2021) · Cancers · doi:10.3390/cancers13061296 · Cited by 9
Marchini, A. M. P. D. S., Gonçalves, L. L., Salgado, M. C. M., do Prado, R. F., Marchini, L., Carvalho, Y. R., & da Rocha, R. F. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.01.008 · Cited by 9
Lakatos, P., Hegedűs, C., Salazar, N., Juarranz, Á., Kövér, K. E., Szabó, É., & Virág, L. (2016) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2016.07.001 · Cited by 9
“a long, branched poly(ADP-ribose) (PAR) polymer that is essential for the recruitment of various adapter and effector DNA repair proteins [18].”
BackgroundSelf-citationTargeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer Therapies
Huang, D., Wang, J., Chen, L., Jiang, W., Inuzuka, H., Simon, D. K., & Wei, W. (2025) · Biomolecules · doi:10.3390/biom15020237 · Cited by 10
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances
Badawy, M. A. S., Braese, S., Ali, T. F. S., Abdel‐Aziz, M., & Abdel-Rahman, H. M. (2025) · Pharmaceuticals · doi:10.3390/ph18101454 · Cited by 10
Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases
Koçak, G., Dimas, M. M., Silva, L., Silva-Amaral, D., Sun, C., Cruddas, S., Barrett, T. G., Martins‐de‐Souza, D., Cunha‐Neto, E., Brocardo, P. S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695486 · Cited by 8
PARP3 Affects Nucleosome Compaction Regulation
Ukraintsev, A. A., Kutuzov, M. M., Belousova, E. A., Joyeau, M., Golyshev, V. M., Lomzov, A. A., & Lavrik, O. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109042 · Cited by 8
Erős, K., Magyar, K., Deres, L., Skázel, Á., Riba, Á., Vámos, Z., Kálai, T., Gallyas, F., Sümegi, B., Tóth, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174401 · Cited by 8
Combined effects of XAF1 and TRAIL on the apoptosis of lung adenocarcinoma cells
Zhang, F., Chen, D., Yang, W., Duan, S., & Chen, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7491 · Cited by 8
Aipire, A., Chen, Q., Cai, S., Li, J., Fu, C., Ying, T., Lu, J., & Li, J. (2018) · Molecules · doi:10.3390/molecules23071687 · Cited by 8
Metadata
- Authors
- Virág, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M., & Oliver, F. J.
- Affiliations
- University of Debrecen (HU)
- Instituto de Parasitología y Biomedicina "López - Neyra" (ES)
- Corresponding author
- Virág, László
- Oliver, Francisco Javier
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 34
- Issue
- 6
- Pages
- 1153-1167
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2076542944
- Cited by
- 273
- References
- 140
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 15 · 2023: 17 · 2022: 23 · 2021: 21 · 2020: 21 · 2019: 20 · 2018: 14 · 2017: 23 · 2016: 29 · 2015: 26 · 2014: 22 · 2013: 13
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Molecular Aspects of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- poly(ADP-ribose) polymerase, necroptosis, parthanatos, apoptosis, autophagic cell death, NAD+ depletion, apoptosis-inducing factor, oxidative stress, cell death signaling
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Mitochondria, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Protein Binding, Protein Processing, Post-Translational, Signal Transduction, Cell Death, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review